Психоонкология: состояние на 2006 г. (расширенный реферат)
Психические расстройства в общей медицине. №3 2007
Психоонкология: состояние на 2006 г. (расширенный реферат)
T.Levin, W.D.Kissane США
Стр. 59-65
4841 просмотров
Опубликовано: 1 марта 2007
Аннотация / Abstract
Введение
В начале XX в. лечение онкологических заболеваний последовательно развивалось и прошло через стадии применения хирургии, лучевой терапии, азотистого иприта. Параллельно развивались психосоматические концепции и клинические исследования в психиатрии. В 1950 г. A.Sutherland стал первым психиатром, работавшим в онкологическом стационаре Мемориального онкологического центра Слоана-Кеттеринга в Нью-Йорке. В Европе R.Feigenberg (1970 г.) начинал работу в Королевском госпитале Стокгольма, S.Greer (1971 г.) из Королевского марсденского госпиталя Лондона и F.Van Dam (1977 г.) основали группу изучения качества жизни в онкологии (EORTC Quality of Life Study Group). В США J.Holland (1977 г.) расширила исследования в Мемориальном центре Слоана-Кеттеринга; A.Weisman (1978 г.) начал исследования терминальных стадий рака в рамках специального проекта (Омега) в Бостоне. Основанием для большинства из этих исследований было общемировое обсуждение, стоит ли онкологическим больным говорить правду об их состоянии. Активная публичная поддержка со стороны потребителей медицинской помощи привела к увеличению доли психосоциальных услуг, умноженных на исследовательские традиции в области психологии, и возрастающие потребности в качественных альтернативах множественным непроверенным психотерапевтическим подходам. Экзистенциальные и духовные проблемы также подчеркивали значимое несоответствие между потребностями умирающих пациентов и возможностью оказания им посильной помощи. Соответственно, в этом направлении и развивались психосоциальные службы.
Каких же высот достиг прогресс за вторую половину XX в., если психоонкология к началу XXI в. выделилась в отдельную специальность? В этой статье с позиций доказательной медицины проанализированы материалы завершенных работ в области психоонкологии, полученных из обобщенных данных метаанализа и систематизированных обзоров, для того чтобы показать самый современный уровень практических подходов в области психосоматики и...
Введение
В начале XX в. лечение онкологических заболеваний последовательно развивалось и прошло через стадии применения хирургии, лучевой терапии, азотистого иприта. Параллельно развивались психосоматические концепции и клинические исследования в психиатрии. В 1950 г. A.Sutherland стал первым психиатром, работавшим в онкологическом стационаре Мемориального онкологического центра Слоана-Кеттеринга в Нью-Йорке. В Европе R.Feigenberg (1970 г.) начинал работу в Королевском госпитале Стокгольма, S.Greer (1971 г.) из Королевского марсденского госпиталя Лондона и F.Van Dam (1977 г.) основали группу изучения качества жизни в онкологии (EORTC Quality of Life Study Group). В США J.Holland (1977 г.) расширила исследования в Мемориальном центре Слоана-Кеттеринга; A.Weisman (1978 г.) начал исследования терминальных стадий рака в рамках специального проекта (Омега) в Бо...
Материал для специалистов
Полный текст статьи доступен только зарегистрированным пользователям.
Вход / Регистрация- 1. Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 2004; 32–9.
- 2. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 57–71.
- 3. Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 2003; 8: 229–40.
- 4. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004; 80–92.
- 5. Chochinov HM, Wilson KG, Enns M, Lander S. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiat 1997; 154: 674–6.
- 6. Kerrihard T, Breitbart W, Dent R, Strout D. Anxiety in patients with cancer and human immunodeficiency virus. Semin Clin Neuropsychiatry 1999; 4: 114–32.
- 7. Stark DP, House A. Anxiety in cancer patients. Br J Cancer 2000; 83: 1261–7.
- 8. Jacobsen PB, Donovan KA, Trask PC et al. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005; 103: 1494–502.
- 9. Zabora J, Brintzenhogeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychosocial distress by cancer site. Psychoncology 2001; 10: 19–28.
- 10. Kissane DW, Grabsch B, Love A et al. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiat 2004; 38: 320–6.
- 11. Levin T, Li Y, Rai D. Quality of life, depression and anxiety in chronic lymphocytic leukemia during phases of "watchful waiting" and active treatment. J Clin Oncol (In press).
- 12. Glassman AH, Stetner F, Walsh BT et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988; 259: 2863–6.
- 13. Glassman AH, Helzer JE, Covey LS et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264: 1546–9.
- 14. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14 (2): 106–23.
- 15. Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135–57.
- 16. Paperwalla KN, Levin TT, Weiner J, Saravay SM. Smoking and depression. Med Clin North Am 2004; 88: 1483–94, x-xi.
- 17. Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 2004; 18: 457–74.
- 18. Hitsman B, Borrelli B, McChargue DE et al. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol 2003; 71: 657–63.
- 19. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2005; 4.
- 20. Lancaster T, Stead LF. Individual behavioural counseling for smoking cessation. Cochrane Database Syst Rev 2005; 4.
- 21. Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 2003; 12: 21–7.
- 22. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002; 54: 1463–70.
- 23. Braithwaite D, Emery J, Walter F et al. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2004; 96: 122–33.
- 24. Jones BA, Kasl SV, Howe CL et al. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 2004; 101: 1293–301.
- 25. French DB, Jones LA. Minority issues in prostate disease. Med Clin North Am 2005; 89: 805–16.
- 26. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am 2005; 89: 771–93.
- 27. Lannin DR, Mathews HF, Mitchell J et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998; 279: 1801–7.
- 28. Soler-Vila H, Kasl SV, Jones BA. Cancer-specific beliefs and survival: a population-based study of African-American and White breast cancer patients. Cancer Causes Control 2005; 16 (2): 105–14.
- 29. Soler-Vila H, Kasl SV, Jones BA. Prognostic significance of psychosocial factors in African-American and white breast cancer patients: a population-based study. Cancer 2003; 98: 1299–308.
- 30. Bach PB, Schrag D, Brawley OW et al. Survival of blacks and whites after a cancer diagnosis. JAMA 2002; 287: 2106–13.
- 31. Holt CL, Lukwago SN, Kreuter MW. Spirituality, breast cancer beliefs and mammography utilization among urban African American women. J Health Psychol 2003; 8: 383–96.
- 32. Moy B, Park ER, Feibelmann S et al. Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women. Psychooncology, 2005.
- 33. Fernandez ME, Palmer RC, Leong-Wu CA. Repeat mammography screening among low-income and minority women: a qualitative study. Cancer Control 2005; 12 (Suppl. 2): 77–83.
- 34. Holland J, Lewis S. The human side of cancer: Living with hope, coping with uncertainty. New York: Harper Collins; 2000.
- 35. Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002; 325: 1066.
- 36. McKenna MC, Zevon MA, Corn B, Rounds J. Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 1999; 18: 520–31.
- 37. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988; 241: 540–5.
- 38. Osborne C, Ostir GV, Du X et al. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat 2005; 93: 41–7.
- 39. Kornblith AB, Herndon JE 2d, Zuckerman E et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 2001; 91: 443–54.
- 40. Lantz PM, House JS, Mero RP, Williams DR. Stress, life events, and socioeconomic disparities in health: results from the Americans' Changing Lives Study. J Health Soc Behav 2005; 46: 274–88.
- 41. Duijts SF, Zeegers MP, Borne BV. The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 2003; 107: 1023–9.
- 42. Ewertz M. Bereavement and breast cancer. Br J Cancer 1986; 53: 701–3.
- 43. Kvikstad A, Vatten LJ, Tretli S, Kvinnsland S. Widowhood and divorce related to cancer risk in middle-aged women. A nested case-control study among Norwegian women born between 1935 and 1954. Int J Cancer 1994; 58: 512–6.
- 44. Lillberg K, Verkasalo PK, Kaprio J et al. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol 2003; 157: 415–23.
- 45. Butow PN, Hiller JE, Price MA et al. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res 2000; 49: 169–81.
- 46. Kissane D, Yates P. Psychological and existential distress. In. O'Connor M, Aranda S (Eds.), Palliative care nursing (2d ed.). Melbourne: Ausmed, 2003.
- 47. Kissane DW, Wein S, Love A et al. The Demoralization Scale. a report of its development and preliminary validation. J Palliat Care 2004; 20: 269–76.
- 48. Morita T, Tsunoda J, Inoue S, Chihara S. An exploratory factor analysis of existential suffering in Japanese terminally ill cancer patients. Psychooncology 2000; 9: 164–8.
- 49. Grandi S, Fabbri S, Tossani E et al. Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom 2001; 70: 176–83.
- 50. Sonino N, Navarrini C, Ruini C et al. Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004; 73: 78–83.
- 51. Clarke DM, Kissane DW, Trauer T, Smith GC. Demoralization, anhedonia and grief in patients with severe physical illness. World Psychiatry 2005; 4: 96–105.
- 52. Grassi L, Travado L, Moncayo FL et al. Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study. J Affect Disord 2004; 83: 243–8.
- 53. Breitbart W. Reframing hope: meaning-centered care for patients near the end of life. Interview by Karen S. Heller. J Palliat Med 2003; 6: 979–88.
- 54. Chochinov HM. Dignity-conserving care – a new model for palliative care: helping the patient feel valued. JAMA 2002; 287: 2253–60.
- 55. Donnelly JM, Kornblith AB, Fleishman S et al. A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partners. Psychooncology 2000; 9: 44–56.
- 56. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 1995; 22: 1369–81.
- 57. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995; 14: 101–8.
- 58. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 1999; 80: 1770–80.
- 59. Classen C, Diamond S, Soleman A et al. Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual. Stanford: Stanford University School of Medicine; 1993.
- 60. Kissane DW, Grabsch B, Clarke DM et al. Supportive-expressive group therapy: the transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies. Psychooncology 2004; 13: 755–68.
- 61. Worden JW. Grief counseling and grief therapy. New York: Springer, 1991.
- 62. Kissane DW, Bloch S, Miach P et al. Cognitive-existential group therapy for patients with primary breast cancer – techniques and themes. Psychooncology 1997; 6: 25–33.
- 63. Yalom ID. Existential psychotherapy. New York, NY: Basic Books; 1980.
- 64. Moorey S, Greer S. Cognitive behaviour therapy for people with cancer (2d ed.). Oxford: Oxford University Press, 2002.
- 65. Kissane DW, Bloch S. Family focused grief therapy. A model of family-centered care during palliative care and bereavement. Buckingham: Open University Press, 2002.
- 66. Folkman S, Moskowitz JT. Coping: pitfalls and promise. Annu Rev Psychol 2004; 55: 745-74.
- 67. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888-91.
- 68. Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 1998; 7: 508–17.
- 69. Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 1999; 8: 295–305.
- 70. Goodwin PJ, Leszcz M, Ennis M et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345: 1719–26.
- 71. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990; 8: 356–64.
- 72. Fawzy FI, Fawzy NW, Hyun CS et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681–9.
- 73. Ratcliffe M, Dawson A, Walker L. Eysenck personality inventory l-scores in patients with hodgkin's disease and non-hodgkin's lymphoma. Psychooncology 1995; 4: 39–45.
- 74. Kuchler T. Impact of psychotherapeutic support ongastrointestinal cancer patients undregoing surgery: Survival results of a trial. Hepatogastroenterology 1999; 46: 322–335.
- 75. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer 1982; 49: 1048–55.
- 76. Ilnyckyj A, Farber J, Cheang M, Weinerman B. A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Physicians Surg Can 1994; 27: 93–6.
- 77. Spiegel D. Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002; 2: 383–9.
- 78. Watson M, Haviland JS, Greer S et al. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999; 354: 1331–6.
- 79. Lerman C, Hanjani P, Caputo C et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992; 10: 330–3.
- 80. Kogon MM, Biswas A, Pearl D et al. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma. Cancer 1997; 80: 225–30.
- 81. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10–30.
- 82. Travis LB, Rabkin CS, Brown LM et al. Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006; 98: 15–25.
- 83. Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 2005; 41: 2613–9.
- 84. Kornblith AB, Herndon JE 2d, Weiss RB et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003; 98: 679–89.
- 85. Casso D, Buist DS, Taplin S. Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004; 2: 25.
- 86. Kornblith AB. Psychosocial adaptation of cancer survivors: New York: Oxford University Press; 1998.
- 87. Deimling GT, Bowman KF, Sterns S et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 2006; 15: 306–20.
- 88. Ahles TA, Saykin AJ, Furstenberg CT et al. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol 2005; 23: 4399–405.
- 89. Ganz PA, Desmond KA, Leedham B et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002; 94: 39–49.
- 90. Mandelblatt J, Figueiredo M, Cullen J. Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? Health Qual Life Outcomes 2003; 1: 45.
- 91. Carver C, Smith R, Antoni M et al. Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psicol 2005; 24 (5): 508.
- 92. Carver CS, Smith RG, Petronis VM, Antoni MH. Quality of life among long-term survivors of breast cancer: different types of antecedents predict different classes of outcomes. Psychooncology 2005.
- 93. Hudson MM, Mertens AC, Yasui Y et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 2003; 290: 1583–92.
- 94. Mertens AC, Yasui Y, Neglia JP et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163–72.
- 95. Castellino SM, Casillas J, Hudson MM et al. Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study. J Clin Oncol 2005; 23: 6499–507.
- 96. Ahles TA, Saykin AJ, Noll WW et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 2003; 12: 612–9.
- 97. Dunn SM, Butow PN, Tattersall MH et al. General information tapes inhibit recall of the cancer consultation. J Clin Oncol 1993; 11: 2279–85.
- 98. Fallowfield L, Hall A, Maguire GP, Baum M. Psychological outcomes in women with early breast cancer. BMJ 1990; 301: 1394.
- 99. Fallowfield L, Jenkins V, Farewell V et al. Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 2002; 359: 650–6.
- 100. Fallowfield L, Jenkins V, Farewell V, Solis-Trapala I. Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer 2003; 89: 1445–9.
- 101. Razavi D, Merckaert I, Marchal S et al. How to optimize physicians' communication skills in cancer care: results of a randomized study assessing the usefulness of posttraining consolidation workshops. J Clin Oncol 2003; 21: 3141–9.
- 102. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794–811.
- 103. Maslach C, Jackson SE. The measurement of experienced burnout. J Occup Behav 1981; 2: 99–113.
- 104. Ramirez AJ, Graham J, Richards MA et al. Burnout and psychiatric disorder among cancer clinicians. Br J Cancer 1995; 71: 1263–9.
- 105. Graham J, Ramirez AJ, Cull A et al. Job stress and satisfaction among palliative physicians. Palliat Med 1996; 10: 185–94.
- 106. Maslach C, Jackson SE, Leiter MP. Maslach burnout inventory. Palo Alto, CA: Consulting Psychologists Press; 1986.
- 107. Maslach C, Jackson S, Leiter M. The maslach burnout inventory (3 ed). Palo Alto, CA: Consulting Psychologist Press; 1996.
- 108. Ramirez AJ, Graham J, Richards MA et al. Mental health of hospital consultants: the effects of stress and satisfaction at work. Lancet 1996; 347: 724–8.
- 109. McMurray JE, Linzer M, Konrad TR et al. The work lives of women physicians results from the physician work life study. The SGIM Career Satisfaction Study Group. J Gen Intern Med 2000; 15: 372–80.
- 110. Vaillant GE, Sobowale NC, McArthur C. Some psychologic vulnerabilities of physicians. N Engl J Med 1972; 287: 372–5.
- 111. Grunfeld E, Whelan TJ, Zitzelsberger L et al. Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction. CMAJ 2000; 163: 166–9.
- 112. Taylor C, Graham J, Potts HW et al. Changes in mental health of UK hospital consultants since the mid-1990s. Lancet 2005; 366: 742–4.
- 113. Jeffcoate W. Care and despair in the UK National Health Service. Lancet 2005; 366: 694–5.
- 114. Spickard AJr, Gabbe SG, Christensen JF. Mid-career burnout in generalist and specialist physicians. JAMA 2002; 288: 1447–50.
- 115. van der Klink JJ, Blonk RW, Schene AH, van Dijk FJ. The benefits of interventions for work-related stress. Am J Public Health 2001; 91: 270–6.
- 116. Quality of Care and Health Outcomes Committee. Guidelines for the development and implementation of clinical practice guidelines: Canberra: AGPS; 1995. Psychooncology: the state of its development in 2006. Eur J Psychiat 2006; 20 (3): 183–97. А.В.Бурлаков